Prifetrastat
KAT6-IN-1 (compound E) is a potent inhibitor of histone acetyltransferases KAT6A and KAT6B. KAT6-IN-1 can be used in cancer research[1].
Product Specifications
CAS Number
2569008-99-5
UNSPSC
12352005
Target
Histone Acetyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kat6-in-1.html
Purity
99.62
Solubility
DMSO : 4 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=S(NC1=NOC2=CC(CN3N=CC=C3)=CC(OC)=C21)(C4=C(OC)C=CC=C4)=O
Molecular Formula
C19H18N4O5S
Molecular Weight
414.44
References & Citations
[1]Paul AS, et, al. Kat6 inhibitor methods and combinations for cancer treatment. WO2022013369.|[2]Stupple PA, et al., Kat6 inhibitor methods and combinations for cancer treatment. WO2022013369.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC402833 20 µg
Thymosin beta 10 (TMSB10) (NM_021103) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC740745-500 1x 500 µL
CD45 / LCA (2B11 + PD7/26), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880020-100 1x 100 µL
Cytokeratin 19 (A53-B/A2.26), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details